|Bid||0.00 x 1100|
|Ask||0.00 x 800|
|Day's Range||91.10 - 95.38|
|52 Week Range||52.17 - 109.05|
|Beta (3Y Monthly)||1.19|
|PE Ratio (TTM)||88.02|
|Earnings Date||Dec 3, 2018 - Dec 7, 2018|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||105.83|
CNBC's Jim Cramer reveals how the Fed’s rose-colored glasses could impact your money. The "Mad Money" host also hears from the CEOs of First Horizon National and Veeva Systems. In the lightning round, Cramer admits he's surprised by a restaurant chain's performance.
Veeva's (VEEV) Vault SiteDocs Platform conducts high-quality, compliant clinical trials with greater visibility to researchers.
Control4, Nine Energy, Cloudera, j2 Global and Veeva Systems highlighted as Zacks Bull and Bear of the Day
In a matter of just a few years, "the Cloud" has evolved from a budding new tech feature to one of the main factors driving growth in the technology sector. With this in mind, we've highlighted three stocks that are showing strong cloud-related activity. Check out these three cloud stocks to buy right now!
Veeva Systems (VEEV) today introduced its first application specifically built for clinical research centers, Veeva Vault SiteDocs. The new solution will help sites more effectively manage regulatory documentation and trial information to speed clinical research. Now clinical research centers can reduce the administrative burden of executing studies by streamlining document and trial processes for site qualification, study activation, and investigator site file management.
The Dow Jones industrials and S&P 500 reversed higher. The small-cap S&P 600 hasn't hit bear-market territory, but chances that small and midcap stocks will enter a 10% decline are rising.
The major stock indexes were volatile in the wake of the September jobs report. Netflix and Costco were breaking down below their 50-day lines.
Medidata's (MDSO) Clinical Cloud platform is likely to provide it a competitive edge in the MedTech space. However, cutthroat competition in the niche space is a headwind.
If you want to know who really controls Veeva Systems Inc (NYSE:VEEV), then you’ll have to look at the makeup of its share registry. Institutions will often hold stock in Read More...
Merit Medical (MMSI) to leverage on Cianna Medical's SAVI and SCOUT platforms. The company plans to retain Cianna Medical's commercial and R&D teams after closure of the transaction.
Per the agreement, Baxter (BAX) and Mayo Clinic researchers to form an outpatient clinic for kidney disease management, home dialysis and in-center dialysis services.
Veeva Systems , a leading provider of industry cloud solutions for the global life sciences industry, will host its financial analyst and investor day in New York on Thursday, October 4, 2018.
Veeva (VEEV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Abbott's (ABT) receipt of FDA approval for XIENCE Sierra coronary stent system as well as a reimbursement approval in Japan for the same device will help it revive the dull Vascular business.